Master Class Livestream

Course Goal and Overview

The goal of this course is to assist oncologists with assessing and improving their skills in the diagnosis, treatment, and management of a wide range of cancers.

This innovative, live via live stream, two-day curriculum provides a comprehensive update on oncologic clinical practice, including current best practices and guidelines, emerging clinical evidence, and recent expert opinion. Highly interactive presentations are followed by lively discussion sessions, including both Q&A and panel discussion formats. Learners are encouraged to submit their most difficult cases and clinical questions, building clinical skills through exposure to practice and patient care standards set by the master clinicians of Dana-Farber Cancer Institute.

Delivering the same education, all from the comforts of your home or office – at a discounted rate.

Target Audience

The Master Class Livestream curriculum is intended to educate practicing community medical oncologists across the US.

Accreditation and Designation


In support of improving patient care, this activity has been planned and implemented by CME Outfitters, LLC and Dana-Farber Cancer Institute. CME Outfitters, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


CME Outfitters, LLC, designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement


MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learners must provide their Date of Birth (MM/DD) and ABIM ID# to Dana-Farber Cancer Institute to claim points for this activity.


Dana-Farber Cancer Institute gratefully acknowledges organizations for providing educational grants or financial support for this activity.

  • Astellas Pharma (Gastrointestinal Cancers and Genitourinary Cancers Tracks)
  • AstraZeneca Pharmaceuticals (Women’s Cancers, Genitourinary Cancers, Malignant and Non-Malignant Hematology Tracks)
  • Bayer HealthCare (Sarcoma Track)
  • Daiichi Sankyo, Inc. (Women’s Cancers and Lung, Head, and Neck and Thyroid Cancers Tracks)
  • Exelixis, Inc. (Lung, Head, and Neck and Thyroid Cancers and Genitourinary Cancers Tracks)
  • GlaxoSmithKline (All Tracks)
  • Merck Sharp & Dohme LLC (Women’s Cancers Track)
  • Novartis Pharmaceuticals Corporation (All Tracks)
  • Pfizer Inc. (All Tracks)
  • Taiho Oncology, Inc. (All Tracks)


Registration for the live stream, two-day course is $350 and includes access to pdfs of faculty presentations as well as the recorded live course via the website. An electronic syllabus will be available via the website the day before the start of the live stream.

Pdfs of faculty presentations will be available 24 hours prior to the start of the course. The recordings from the live course will be available via the website beginning on November 11, 2022.

Livestream Access Information

Information on how to access the livestream available to registrants only.

October 21 - 22, 2022



This activity has sold out. Add yourself to the waiting list below to be notified if/when tickets become available again.

Your email address will not be shared or used for anything other than being notified of this item being re-stocked.

View Schedule View Faculty